The Prognosis of Papillary Thyroid Cancer with Initial Distant Metastasis is Strongly Associated with Extensive Extrathyroidal Extension: A Retrospective Cohort Study

BackgroundExtensive extrathyroidal extension (ETE) has a significant role in the prognosis of papillary thyroid cancer (PTC) without distant metastasis, but its role in PTC with initial distant metastasis has never been studied. This study aimed to evaluate the prognostic significance of extensive ETE regarding disease progression, survival, and remission in PTC patients with initial distant metastasis.MethodsThis retrospective cohort study included PTC patients with initial distant metastasis who underwent total thyroidectomy with a median follow-up period of 6.7 years. The prognostic significance of extensive ETE was assessed in terms of time to tumor progression (TTP), cancer-specific survival (CSS), and cumulative incidence of remission with all-cause death as the competing event.ResultsThe study enrolled 64 patients. Of these patients, 21 (32.8%) had extensive ETE, which was associated with a shorter TTP (adjusted hazard ratio [HR], 4.10; p = 0.015) and a lower CSS rate (p = 0.002, log-rank), particularly for patients 55 years of age or older with stage 4b disease (10-year CSS rate: 33.3% in those with and 92.3% in those without extensive ETE; p = 0.017). Additionally, remission was observed only in patients without extensive ETE (10-year cumulative incidence of remission: 0.0% in those with and 29.3% in those without extensive ETE; p = 0.013).ConclusionsExtensive ETE of the primary lesion results in poorer prognoses for PTC patients with initial distant metastasis. The high CSS rate for patients with stage 4b PTC but no extensive ETE indicates that the prognosis of this patient population should be distinguished from that of other stage 4 cases.

[1]  L. Schwartz,et al.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.

[2]  Jandee Lee,et al.  Differentiated Thyroid Carcinoma Presenting With Distant Metastasis at Initial Diagnosis: Clinical Outcomes and Prognostic Factors , 2010, Annals of surgery.

[3]  S. Roman,et al.  Projecting Survival in Papillary Thyroid Cancer: A Comparison of the Seventh and Eighth Editions of the American Joint Commission on Cancer/Union for International Cancer Control Staging Systems in Two Contemporary National Patient Cohorts. , 2017, Thyroid : official journal of the American Thyroid Association.

[4]  B. Lang,et al.  Evaluating the Prognostic Factors Associated with Cancer-specific Survival of Differentiated Thyroid Carcinoma Presenting with Distant Metastasis , 2012, Annals of Surgical Oncology.

[5]  E. Bergstralh,et al.  Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables. , 1988, The Journal of clinical endocrinology and metabolism.

[6]  I. Sugitani,et al.  Papillary thyroid carcinoma with distant metastases: survival predictors and the importance of local control. , 2008, Surgery.

[7]  Diane D. Liu,et al.  Erratum to: Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis , 2015, Breast Cancer Research and Treatment.

[8]  C. Benbassat,et al.  LONG-TERM OUTCOMES AND PROGNOSTIC FACTORS IN PATIENTS WITH DIFFERENTIATED THYROID CANCER AND DISTANT METASTASES. , 2017, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[9]  Kaliszewski,et al.  American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer : The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer , 2017 .

[10]  Sun Wook Cho,et al.  Long-term prognosis of differentiated thyroid cancer with lung metastasis in Korea and its prognostic factors. , 2014, Thyroid : official journal of the American Thyroid Association.

[11]  Z. Hall Cancer , 1906, The Hospital.

[12]  A. Jemal,et al.  Annual Report to the Nation on the status of cancer, 1975‐2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer , 2014, Cancer.

[13]  B. Markoski,et al.  The importance of age over radioiodine avidity as a prognostic factor in differentiated thyroid carcinoma with distant metastases. , 2009, Thyroid : official journal of the American Thyroid Association.

[14]  S. Roman,et al.  Exploring the Relationship Between Patient Age and Cancer-Specific Survival in Papillary Thyroid Cancer: Rethinking Current Staging Systems. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  J. Shah,et al.  Differentiated thyroid cancer presenting initially with distant metastasis. , 1997, American journal of surgery.

[16]  J. Chung,et al.  Prognostic indicators of outcomes in patients with lung metastases from differentiated thyroid carcinoma during long‐term follow‐up , 2018, Clinical endocrinology.

[17]  H Putter,et al.  Tutorial in biostatistics: competing risks and multi‐state models , 2007, Statistics in medicine.

[18]  Stephanie L. Lee,et al.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[19]  E. Baudin,et al.  Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. , 2006, The Journal of clinical endocrinology and metabolism.

[20]  A. Buck,et al.  Life expectancy is reduced in differentiated thyroid cancer patients ≥ 45 years old with extensive local tumor invasion, lateral lymph node, or distant metastases at diagnosis and normal in all other DTC patients. , 2013, The Journal of clinical endocrinology and metabolism.

[21]  C. Harmer,et al.  Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome , 2005, Clinical endocrinology.

[22]  Haesook T. Kim Cumulative Incidence in Competing Risks Data and Competing Risks Regression Analysis , 2007, Clinical Cancer Research.

[23]  J. Cooper Ajcc Cancer Staging Manual , 1997 .

[24]  Quan-Yong Luo,et al.  Pulmonary metastases in differentiated thyroid cancer: efficacy of radioiodine therapy and prognostic factors. , 2015, European journal of endocrinology.

[25]  C. Bal,et al.  Lung metastases from differentiated thyroid carcinoma: prognostic factors related to remission and disease‐free survival , 2015, Clinical endocrinology.

[26]  C. Balch,et al.  AJCC Cancer Staging Manual. 6th ed , 2002 .

[27]  Initial Size of Metastatic Lesions Is Best Prognostic Factor in Patients with Metastatic Differentiated Thyroid Carcinoma Confined to the Lung. , 2017, Thyroid : official journal of the American Thyroid Association.

[28]  R. Tsang,et al.  Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis , 2007, Cancer.

[29]  C. Hsueh,et al.  Papillary thyroid carcinomas with lung metastases. , 2004, Thyroid : official journal of the American Thyroid Association.

[30]  H. Biersack,et al.  Distinguishing synchronous from metachronous manifestation of distant metastases: a prognostic feature in differentiated thyroid carcinoma , 2017, European Journal of Nuclear Medicine and Molecular Imaging.

[31]  Tae Yong Kim,et al.  Early prognostic factors at the time of diagnosis of bone metastasis in patients with bone metastases of differentiated thyroid carcinoma. , 2016, European journal of endocrinology.

[32]  J. Shah,et al.  The impact of distant metastases at presentation on prognosis in patients with differentiated carcinoma of the thyroid gland. , 2012, Thyroid : official journal of the American Thyroid Association.

[33]  F. Chung-Yau Lo MS,et al.  Prognostic Factors in Papillary and Follicular Thyroid Carcinoma: Their Implications for Cancer Staging , 2006, Annals of Surgical Oncology.

[34]  Louise Davies,et al.  Increasing incidence of thyroid cancer in the United States, 1973-2002. , 2006, JAMA.

[35]  D. Papathanassiou,et al.  Prognostic Value of 18F-FDG PET/CT Metabolic Parameters in Metastatic Differentiated Thyroid Cancers , 2015, Clinical nuclear medicine.

[36]  S. Dinneen,et al.  Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades. , 1995, The Journal of clinical endocrinology and metabolism.

[37]  J. Shah,et al.  Multi-organ distant metastases confer worse disease-specific survival in differentiated thyroid cancer. , 2014, Thyroid : official journal of the American Thyroid Association.

[38]  E. Baudin,et al.  Do histological, immunohistochemical, and metabolic (radioiodine and fluorodeoxyglucose uptakes) patterns of metastatic thyroid cancer correlate with patient outcome? , 2011, Endocrine-related cancer.

[39]  GanlyIan,et al.  Multi-Organ Distant Metastases Confer Worse Disease-Specific Survival in Differentiated Thyroid Cancer , 2014 .

[40]  B. Lang,et al.  Prognostic Factors in Papillary and Follicular Thyroid Carcinoma: Their Implications for Cancer Staging , 2007, Annals of surgical oncology.

[41]  Eva Negri,et al.  Thyroid cancer mortality and incidence: A global overview , 2015, International journal of cancer.

[42]  C. Hsieh,et al.  Long‐term outcomes of distant metastasis from differentiated thyroid carcinoma , 2012, Clinical endocrinology.

[43]  J. Shah,et al.  Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma. , 2003, Journal of the American College of Surgeons.

[44]  Tae Yong Kim,et al.  Prognosis of Differentiated Thyroid Carcinoma with Initial Distant Metastasis: A Multicenter Study in Korea , 2018, Endocrinology and metabolism.

[45]  S. Mandel,et al.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[46]  I. Sugitani,et al.  Prognostic factors and the therapeutic strategy for patients with bone metastasis from differentiated thyroid carcinoma. , 2010, Surgery.

[47]  M. Ranney,et al.  Beyond the bedside: Clinicians as guardians of public health, medicine and science , 2020, The American Journal of Emergency Medicine.